Applicant profile

Ortho-Clinical Diagnostics

Ortho-Clinical Diagnostics, Inc.
Hong Kong MDACS·United Kingdom·7 registered devices·Feb 03, 2021Jun 28, 2022
7
Total devices
1
Risk classes
2021
First registration
2022
Most recent
Applicant overview
Bilingual manufacturer details sourced from Hong Kong MDACS
Applicant (EN)
Ortho-Clinical Diagnostics
Applicant (ZH)
Ortho-Clinical Diagnostics, Inc.
Country
United Kingdom
英国
Address
Felindre Meadows, Pencoed, Bridgend CF35 5PZ, United Kingdom
Felindre Meadows, Pencoed, Bridgend CF35 5PZ, 英国
Timeline
First registration
Feb 03, 2021
Most recent
Jun 28, 2022
Risk class breakdown
D
7
Recent MDACS registrations
Latest 15 devices linked to this applicant
DeviceRisk classAuthorised repRegistered
IVD Test Reagent/Kits, Serology, Virus, Hepatitis B, Surface Antigen
体外诊断 检测试剂/试剂盒、血清学、病毒、乙型肝炎、表面抗原
DDCH Auriga (Hong Kong) Limited
奥利佳(香港)有限公司
Jun 28, 2022
IVD Test Reagent/Kits, Serology, Virus, Hepatitis C, Antibody
体外诊断 检测试剂/试剂盒、血清学、病毒、丙型肝炎、抗体
DDCH Auriga (Hong Kong) Limited
奥利佳(香港)有限公司
Feb 16, 2022
IVD Test Reagent/Kits, Serology, Virus, Hepatitis B, Surface Antigen
体外诊断 检测试剂/试剂盒、血清学、病毒、乙型肝炎、表面抗原
DDCH Auriga (Hong Kong) Limited
奥利佳(香港)有限公司
Dec 10, 2021
IVD Test Reagent/Kits, Serology, Virus, Hepatitis B, Core Antibody
体外诊断 检测试剂/试剂盒、血清学、病毒、乙型肝炎、核心抗体
DDCH Auriga (Hong Kong) Limited
奥利佳(香港)有限公司
Dec 10, 2021
IVD Test Reagent/Kits, Serology, Virus, Hepatitis B, Surface Antigen, Confirmatory
体外诊断 检测试剂/试剂盒、血清学、病毒、乙型肝炎、表面抗原、确认性
DDCH Auriga (Hong Kong) Limited
奥利佳(香港)有限公司
Dec 10, 2021
IVD Test Reagent/Kits, Serology, Virus, Hepatitis B, Surface Antigen, Confirmatory
体外诊断 检测试剂/试剂盒、血清学、病毒、乙型肝炎、表面抗原、确认性
DDCH Auriga (Hong Kong) Limited
奥利佳(香港)有限公司
Dec 10, 2021
IVD Test Reagent/Kits, Serology, Virus, Retrovirus, HIV-1/2, Antibody
体外诊断 检测试剂/试剂盒、血清学、病毒、逆转录病毒、HIV-1/2、抗体
DDCH Auriga (Hong Kong) Limited
奥利佳(香港)有限公司
Feb 03, 2021
About this profile

Ortho-Clinical Diagnostics is associated with 7 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.